Literature DB >> 23317300

Indirect osteotome maxillary sinus floor elevation: an update.

Javier Romero-Millán1, Luis Martorell-Calatayud, Maria Peñarrocha, Berta García-Mira.   

Abstract

The objective was to review publications on indirect osteotome maxillary sinus floor elevation (OMSFE) procedures. Studies published between 1999 and 2010 on patients with a minimum of 1 year of follow-up were analyzed. Fourteen studies were included. Indirect OMSFE is indicated for a bone height of 6-8 mm. More bone height was gained when graft material was used. Schneiderian membrane perforation was the most frequent complication. Survival rates varied between 93.5% and 100%. Osteotome sinus membrane elevation is a predictable and effective procedure for placing implants in areas of the posterior maxilla with low bone height.

Entities:  

Mesh:

Year:  2012        PMID: 23317300     DOI: 10.1563/AAID-JOI-D-11-00160

Source DB:  PubMed          Journal:  J Oral Implantol        ISSN: 0160-6972            Impact factor:   1.779


  4 in total

1.  An alternative maxillary sinus lift technique - sinu lift system.

Authors:  Parthasaradhi T; Shivakumar B; T S S Kumar; Ashish R Jain; Suganya P
Journal:  J Clin Diagn Res       Date:  2015-03-01

2.  A simplified approach to the minimally invasive antral membrane elevation technique utilizing a viscoelastic medium for hydraulic sinus floor elevation.

Authors:  Georgios A Kotsakis; Ziv Mazor
Journal:  Oral Maxillofac Surg       Date:  2014-11-18

3.  Long-Term Clinical Study of Implants Placed in Maxillary Sinus Floor Augmentation Using Beta-Tricalcium Phosphate.

Authors:  Eugenio Velasco-Ortega; Angela Sierra-Baztan; Alvaro Jiménez-Guerra; Antonio España-López; Iván Ortiz-Garcia; Enrique Núñez-Márquez; Jesús Moreno-Muñoz; José Luis Rondón-Romero; José López-López; Loreto Monsalve-Guil
Journal:  Int J Environ Res Public Health       Date:  2021-09-22       Impact factor: 3.390

4.  Simultaneous and delayed direct sinus lift versus conventional implants: Retrospective study with 5-years minimum follow-up.

Authors:  J Romero-Millán; F Hernández-Alfaro; M Peñarrocha-Diago; D Soto-Peñaloza; D Peñarrocha-Oltra; M-A Peñarrocha-Diago
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.